Wealth Enhancement Advisory Services’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $187K | Sell |
17,305
-5,323
| -24% | -$57.4K | ﹤0.01% | 2994 |
|
|
2025
Q1 | $194K | Sell |
22,628
-4,045
| -15% | -$34.7K | ﹤0.01% | 2616 |
|
|
2024
Q4 | $286K | Buy |
26,673
+10,925
| +69% | +$117K | ﹤0.01% | 2399 |
|
|
2024
Q3 | $89.4K | Buy |
15,748
+1,246
| +9% | +$7.08K | ﹤0.01% | 2541 |
|
|
2024
Q2 | $61.2K | Buy |
14,502
+422
| +3% | +$1.78K | ﹤0.01% | 2429 |
|
|
2024
Q1 | $71.7K | Buy |
14,080
+1,289
| +10% | +$6.56K | ﹤0.01% | 2314 |
|
|
2023
Q4 | $119K | Buy |
12,791
+1,916
| +18% | +$17.8K | ﹤0.01% | 2149 |
|
|
2023
Q3 | $71.2K | Buy |
+10,875
| New | +$71.2K | ﹤0.01% | 2114 |
|